Bgm (BGM) Cash & Equivalents (2019 - 2025)
Bgm (BGM) posted quarterly Cash & Equivalents of $9.8 million for Q3 2025, little changed year-over-year from $9.8 million in Q3 2024, and down 8.2% quarter-over-quarter from $10.7 million in Q1 2025.
Bgm (BGM) Cash & Equivalents (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Cash & Equivalents for 7 consecutive years, with $9.8 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Cash & Equivalents changed 0.02% year-over-year to $9.8 million; the TTM figure through Sep 2025 stood at $9.8 million (changed 0.02% YoY), while the FY2025 annual figure was $9.8 million, changed 0.02% from the prior year.
- Cash & Equivalents retreated to $9.8 million in Q3 2025 per BGM's latest filing, from $10.7 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $16.7 million in Q1 2022 and bottomed at $20.31 in Q1 2021.
- Historically, Cash & Equivalents has averaged $9.7 million across 5 years, with a median of $9.8 million in 2025.
- Annual changes were most pronounced in 2022 — Cash & Equivalents soared 82048261.17% — and 2023, when it sank 60.94%.
- Bgm's Cash & Equivalents stood at $10.5 million in 2021, then surged by 36.8% to $14.3 million in 2022, then tumbled by 60.94% to $5.6 million in 2023, then soared by 75.53% to $9.8 million in 2024, then grew by 0.02% to $9.8 million in 2025.
- Business Quant data shows BGM's Cash & Equivalents at $9.8 million in Q3 2025, $10.7 million in Q1 2025, and $9.8 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Bgm | 30.61 Mn | 20.79 Mn | - | 9.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.82 Mn |
| Mar 31, 2025 | 10.70 Mn |
| Sep 30, 2024 | 9.82 Mn |
| Sep 30, 2023 | 5.59 Mn |
| Mar 31, 2023 | 9.71 Mn |
| Sep 30, 2022 | 14.32 Mn |
| Mar 31, 2022 | 16.67 Mn |
| Sep 30, 2021 | 10.47 Mn |
| Mar 31, 2021 | 20.31 |
| Sep 30, 2020 | 11.87 Mn |
| Sep 30, 2019 | 4.59 Mn |